Survival and Efficacy of Decitabine in Myelodysplastic Syndromes (MDS), Analysis of the 5-Day IV Dosing Regimen.

Autor: Kantarjian, Hagop, Garcia-Manero, Guillermo, O'Brien, Susan, Estrov, Zeev, Ravandi, Farhad, Cortes, Jorge, Shan, Jianqin *, Davisson, Jan *, Issa, Jean-Pierre
Zdroj: In Blood 16 November 2007 110(11):115-115
Databáze: ScienceDirect